{"id":"https://openalex.org/W7171532347","doi":"https://doi.org/10.1111/bju.70387","title":"INtraVESical immunoTherapy ( INVEST ) prior to radical cystectomy for bladder cancer: trial protocol","display_name":"INtraVESical immunoTherapy ( INVEST ) prior to radical cystectomy for bladder cancer: trial protocol","publication_year":2026,"publication_date":"2026-07-27","ids":{"openalex":"https://openalex.org/W7171532347","doi":"https://doi.org/10.1111/bju.70387","pmid":"https://pubmed.ncbi.nlm.nih.gov/42515859"},"language":"en","primary_location":{"id":"doi:10.1111/bju.70387","doi":"https://doi.org/10.1111/bju.70387","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bju.70387","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bju.70387","source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bju.70387","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029181474","display_name":"Ruby Smith Whelan","orcid":"https://orcid.org/0000-0003-4389-8685","observed_orcids":["https://orcid.org/0000-0003-4389-8685"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ruby Lister\u2010Whelan","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK"],"raw_orcid":"https://orcid.org/0000-0003-4389-8685","affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113612366","display_name":"Ethan R Senior","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Ethan Senior","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049587707","display_name":"Jessica Kendall","orcid":"https://orcid.org/0000-0003-2884-4849","observed_orcids":["https://orcid.org/0000-0003-2884-4849"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jessica Kendall","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK"],"raw_orcid":"https://orcid.org/0000-0003-2884-4849","affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045899108","display_name":"Jamie B. Oughton","orcid":"https://orcid.org/0000-0002-2047-804X","observed_orcids":["https://orcid.org/0000-0002-2047-804X"]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jamie B. Oughton","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114282162","display_name":"Dr Fiona Collinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I130828816","display_name":"University of Leeds","ror":"https://ror.org/024mrxd33","country_code":"GB","type":"education","lineage":["https://openalex.org/I130828816"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Fiona Collinson","raw_affiliation_strings":["Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research University of Leeds  Leeds UK","institution_ids":["https://openalex.org/I130828816"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023494141","display_name":"Jon Griffin","orcid":"https://orcid.org/0000-0003-3969-7637","observed_orcids":["https://orcid.org/0000-0003-3969-7637"]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Jon Griffin","raw_affiliation_strings":["Department of Histopathology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK"],"raw_orcid":"https://orcid.org/0000-0003-3969-7637","affiliations":[{"raw_affiliation_string":"Department of Histopathology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I4210102902"]},{"raw_affiliation_string":"Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079982270","display_name":"Rachel Hubbard","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Rachel Hubbard","raw_affiliation_strings":["Department of Radiology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I4210102902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066415190","display_name":"Steven J. Kennish","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Steven Kennish","raw_affiliation_strings":["Department of Radiology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Radiology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I4210102902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022043329","display_name":"Aidan P. Noon","orcid":"https://orcid.org/0000-0002-5999-173X","observed_orcids":["https://orcid.org/0000-0002-5999-173X"]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Aidan Noon","raw_affiliation_strings":["Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I4210102902"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028350848","display_name":"Derek J. Rosario","orcid":"https://orcid.org/0000-0002-9086-3592","observed_orcids":["https://orcid.org/0000-0002-9086-3592"]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Derek J. Rosario","raw_affiliation_strings":["Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I4210102902"]},{"raw_affiliation_string":"Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024006056","display_name":"Irbaz B Riaz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]},{"id":"https://openalex.org/I4210125099","display_name":"Mayo Clinic in Arizona","ror":"https://ror.org/03jp40720","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099"]},{"id":"https://openalex.org/I4390039332","display_name":"Mayo Clinic Comprehensive Cancer Center (Arizona)","ror":"https://ror.org/003xpy695","country_code":null,"type":"healthcare","lineage":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irbaz B. Riaz","raw_affiliation_strings":["Department of Hematology/Oncology Mayo Clinic  Phoenix AZ USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology/Oncology Mayo Clinic  Phoenix AZ USA","institution_ids":["https://openalex.org/I1330342723","https://openalex.org/I4210125099","https://openalex.org/I4390039332"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108560721","display_name":"J. Telliez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"Roche (Switzerland)","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Julie Telliez","raw_affiliation_strings":["F. Hoffmann\u2010La Roche Ltd.  Basel Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann\u2010La Roche Ltd.  Basel Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032231578","display_name":"James W.F. Catto","orcid":"https://orcid.org/0000-0003-2787-8828","observed_orcids":["https://orcid.org/0000-0003-2787-8828"]},"institutions":[{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"James W. F. Catto","raw_affiliation_strings":["Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I4210102902"]},{"raw_affiliation_string":"Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031306593","display_name":"Syed A. Hussain","orcid":"https://orcid.org/0000-0003-1552-511X","observed_orcids":["https://orcid.org/0000-0003-1552-511X"]},"institutions":[{"id":"https://openalex.org/I2802720485","display_name":"Weston Park Cancer Centre","ror":"https://ror.org/042gs1a72","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802720485","https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I4210102902","display_name":"Sheffield Teaching Hospitals NHS Foundation Trust","ror":"https://ror.org/018hjpz25","country_code":"GB","type":"funder","lineage":["https://openalex.org/I4210102902"]},{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Syed A. Hussain","raw_affiliation_strings":["Department of Oncology, Weston Park Cancer and Centre Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Oncology, Weston Park Cancer and Centre Sheffield Teaching Hospitals NHS Foundation Trust  Sheffield UK","institution_ids":["https://openalex.org/I2802720485","https://openalex.org/I4210102902"]},{"raw_affiliation_string":"Division of Clinical Medicine, School of Medicine & Population Health University of Sheffield  Sheffield UK","institution_ids":["https://openalex.org/I91136226"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5031306593"],"corresponding_institution_ids":["https://openalex.org/I2802720485","https://openalex.org/I4210102902","https://openalex.org/I91136226"],"apc_list":{"value":4770,"currency":"USD","value_usd":4770},"apc_paid":{"value":4770,"currency":"USD","value_usd":4770},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.61411449,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"138","issue":"4","first_page":"607","last_page":"619"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10279","display_name":"Urinary Bladder and Prostate Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/atezolizumab","display_name":"atezolizumab","score":0.8510000109672546},{"id":"https://openalex.org/keywords/intravesical-immunotherapy","display_name":"intravesical immunotherapy","score":0.9729999899864197},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.7429999709129333},{"id":"https://openalex.org/keywords/radical-cystectomy","display_name":"radical cystectomy","score":0.8679999709129333},{"id":"https://openalex.org/keywords/high-risk-non-muscle-invasive-bladder-cancer","display_name":"high-risk non-muscle-invasive bladder cancer","score":0.9470000267028809},{"id":"https://openalex.org/keywords/muscle-invasive-bladder-cancer","display_name":"muscle-invasive bladder cancer","score":0.8790000081062317},{"id":"https://openalex.org/keywords/urothelial-carcinoma","display_name":"urothelial carcinoma","score":0.8180000185966492},{"id":"https://openalex.org/keywords/pd-l1-inhibitors","display_name":"PD-L1 inhibitors","score":0.6759999990463257},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.703000009059906},{"id":"https://openalex.org/keywords/safety-and-toxicity","display_name":"safety and toxicity","score":0.6370000243186951},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7730000019073486},{"id":"https://openalex.org/keywords/mass-spectrometry-imaging","display_name":"mass spectrometry imaging","score":0.8659999966621399},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C2775949291","wikidata":"https://www.wikidata.org/wiki/Q20707748","display_name":"Atezolizumab","level":5,"score":0.8945000171661377},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8930000066757202},{"id":"https://openalex.org/C2775910329","wikidata":"https://www.wikidata.org/wiki/Q245995","display_name":"Cystectomy","level":4,"score":0.8285999894142151},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.7261999845504761},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.6189000010490417},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5145999789237976},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5138999819755554},{"id":"https://openalex.org/C2779762690","wikidata":"https://www.wikidata.org/wiki/Q9382","display_name":"Urinary bladder","level":2,"score":0.43369999527931213},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.43220001459121704},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.39469999074935913},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.38830000162124634},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3871999979019165},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.3788999915122986},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.36899998784065247},{"id":"https://openalex.org/C31174226","wikidata":"https://www.wikidata.org/wiki/Q64855140","display_name":"Perioperative","level":2,"score":0.35440000891685486},{"id":"https://openalex.org/C2777546739","wikidata":"https://www.wikidata.org/wiki/Q33525","display_name":"Carcinoma","level":2,"score":0.35100001096725464},{"id":"https://openalex.org/C2778065480","wikidata":"https://www.wikidata.org/wiki/Q2501186","display_name":"Transitional cell carcinoma","level":4,"score":0.3278999924659729},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.31929999589920044},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.3158000111579895},{"id":"https://openalex.org/C2777472916","wikidata":"https://www.wikidata.org/wiki/Q1164529","display_name":"Renal cell carcinoma","level":2,"score":0.3061000108718872},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3059999942779541},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3052000105381012},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2712000012397766},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.2624000012874603},{"id":"https://openalex.org/C2910508445","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder Neoplasm","level":4,"score":0.25920000672340393}],"mesh":[{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000074322","descriptor_name":"Antineoplastic Agents, Immunological","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000093284","descriptor_name":"Non-Muscle Invasive Bladder Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093284","descriptor_name":"Non-Muscle Invasive Bladder Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093284","descriptor_name":"Non-Muscle Invasive Bladder Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093284","descriptor_name":"Non-Muscle Invasive Bladder Neoplasms","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000283","descriptor_name":"Administration, Intravesical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D001749","descriptor_name":"Urinary Bladder Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D015653","descriptor_name":"Cystectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015653","descriptor_name":"Cystectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015653","descriptor_name":"Cystectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015653","descriptor_name":"Cystectomy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017321","descriptor_name":"Clinical Trials, Phase I as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1111/bju.70387","doi":"https://doi.org/10.1111/bju.70387","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bju.70387","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bju.70387","source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},{"id":"pmid:42515859","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42515859","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU international","raw_type":"Journal Article"},{"id":"pmh:oai:eprints.whiterose.ac.uk:243982","doi":null,"is_oa":true,"landing_page_url":"https://orcid.org/0000-0003-4389-8685>,","pdf_url":"https://eprints.whiterose.ac.uk/id/eprint/243982/1/BJU%20International%20-%202026%20-%20Lister%E2%80%90Whelan%20-%20INtraVESical%20immunoTherapy%20%20INVEST%20%20prior%20to%20radical%20cystectomy%20for%20bladder.pdf","source":{"id":"https://openalex.org/S4306400854","display_name":"White Rose Research Online (University of Leeds, The University of Sheffield, University of York)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I2800616092","host_organization_name":"White Rose University Consortium","host_organization_lineage":["https://openalex.org/I2800616092"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13550807","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13550807/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13550807/pdf/BJU-138-607.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"BJU Int","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/bju.70387","doi":"https://doi.org/10.1111/bju.70387","is_oa":true,"landing_page_url":"https://doi.org/10.1111/bju.70387","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bju.70387","source":{"id":"https://openalex.org/S191188855","display_name":"British Journal of Urology","issn_l":"1464-4096","issn":["1464-4096","1464-410X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BJU International","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.6786737442016602,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/study-protocol","display_name":"Study Protocol"}],"awards":[{"id":"https://openalex.org/G4059932851","display_name":null,"funder_award_id":"MO43103","funder_id":"https://openalex.org/F4320307779","funder_display_name":"Roche"}],"funders":[{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7171532347.pdf","grobid_xml":"https://content.openalex.org/works/W7171532347.grobid-xml"},"referenced_works_count":24,"referenced_works":["https://openalex.org/W1966900148","https://openalex.org/W1971208896","https://openalex.org/W2002045993","https://openalex.org/W2017208817","https://openalex.org/W2026576427","https://openalex.org/W2065151446","https://openalex.org/W2113964885","https://openalex.org/W2124427232","https://openalex.org/W2135220383","https://openalex.org/W2163634558","https://openalex.org/W2436471487","https://openalex.org/W2549925369","https://openalex.org/W2559804019","https://openalex.org/W2893677042","https://openalex.org/W2921668280","https://openalex.org/W3113334560","https://openalex.org/W4280542446","https://openalex.org/W4292688946","https://openalex.org/W4316038236","https://openalex.org/W4317682362","https://openalex.org/W4376645144","https://openalex.org/W4390669877","https://openalex.org/W4399388464","https://openalex.org/W4402552345"],"related_works":[],"abstract_inverted_index":{"BACKGROUND:":[0],"High-risk":[1],"non-muscle-invasive":[2],"bladder":[3,73,90,137,203],"cancer":[4,74,91,138],"(HRNMIBC)":[5],"has":[6],"a":[7,109,161,291],"variable":[8],"prognosis,":[9],"managed":[10],"predominantly":[11],"by":[12,160,190,237,253,268],"local":[13],"surgical":[14],"resection":[15],"and":[16,33,130,155,169,182,193,216,228,239,257],"intravesical":[17,79,126,187],"Bacillus":[18],"Calmette-Gu\u00e9rin":[19],"(BCG),":[20],"or":[21,88,272,285,294],"radical":[22],"cystectomy":[23],"(RC).":[24],"Current":[25],"treatments":[26],"are":[27,44,95],"poorly":[28],"tolerated,":[29],"have":[30,53],"supply":[31],"limitations":[32,43],"often":[34],"fail":[35],"to":[36,46,165,178,208],"control":[37],"the":[38,172,197,276],"disease.":[39],"Treatments":[40],"overcoming":[41],"these":[42],"needed":[45],"improve":[47],"HRNMIBC":[48,87],"outcomes.":[49],"Many":[50],"novel":[51],"agents":[52],"been":[54],"approved":[55],"in":[56,92,134,200],"recent":[57],"years":[58],"(including":[59],"systemic":[60],"pembrolizumab,":[61],"nogapendekin":[62],"alfa":[63],"inbakicept-pmln,":[64],"N-803),":[65],"but":[66],"long-term":[67],"efficacy":[68],"is":[69,108],"unknown.":[70],"Given":[71],"advanced":[72],"findings,":[75],"we":[76],"believe":[77],"direct":[78,131,194,273],"administration":[80,124],"of":[81,119,186,247],"atezolizumab":[82,123,157,188,248],"may":[83],"aid":[84],"with":[85,136,139,202],"managing":[86],"muscle-invasive":[89],"patients":[93,135,201],"who":[94],"ineligible":[96],"for":[97,299],"cisplatin-based":[98],"neoadjuvant":[99],"chemotherapy.":[100],"STUDY":[101],"DESIGN:":[102],"The":[103],"INtraVESical":[104],"immunoTherapy":[105],"(INVEST)":[106],"trial":[107],"UK-based,":[110],"open-label,":[111],"non-randomised,":[112],"single-centre,":[113],"Phase":[114],"Ib":[115],"dose":[116,149,162,213,293],"escalation,":[117],"window":[118],"opportunity":[120],"study":[121],"exploring":[122],"via":[125],"routes":[127],"(passive":[128],"instillation":[129,192,271],"injection":[132,195,274],"[sub-urothelial])":[133],"all":[140],"stages":[141],"undergoing":[142],"RC.":[143,209],"For":[144],"both":[145],"routes,":[146],"an":[147],"initial":[148],"confirmation":[150],"stage":[151,164],"will":[152,264,280],"determine":[153],"toxicity":[154,170],"recommended":[156,173],"dosage,":[158],"followed":[159],"expansion":[163],"further":[166],"evaluate":[167],"safety":[168,180],"at":[171,242],"dose.":[174],"ENDPOINTS:":[175],"We":[176],"aim":[177],"investigate":[179],"(primary)":[181],"preliminary":[183],"activity":[184],"(secondary)":[185],"delivered":[189],"passive":[191,270],"into":[196,275],"tumour/bladder":[198,277],"wall":[199],"urothelial":[204],"cell":[205],"carcinoma":[206],"prior":[207],"Primary":[210],"endpoints":[211,220,232],"include":[212,221,233],"limiting":[214],"toxicities":[215],"adverse":[217],"events.":[218],"Secondary":[219],"progression-free":[222],"survival,":[223],"pathological":[224],"complete":[225],"response":[226],"rate":[227],"treatment":[229],"compliance.":[230],"Exploratory":[231],"pharmacokinetic":[234],"profile":[235],"(assessed":[236],"serum":[238],"urine":[240],"concentrations":[241],"prespecified":[243],"timepoints),":[244],"spatial":[245],"analysis":[246],"distribution":[249],"within":[250],"RC":[251],"tissue":[252],"imaging":[254],"mass":[255],"spectrometry":[256],"overall":[258],"survival.":[259],"PATIENTS":[260],"AND":[261],"METHODS:":[262],"Atezolizumab":[263],"be":[265],"administered":[266,289],"intravesically":[267],"either":[269,282],"wall.":[278],"Cohorts":[279],"receive":[281],"600":[283],"mg":[284,287],"1200":[286],"doses":[288,297],"as":[290,295],"single":[292],"multiple":[296],"(weekly":[298],"3-6":[300],"weeks).":[301],"TRIAL":[302],"REGISTRATION:":[303],"International":[304],"Standard":[305],"Randomised":[306],"Controlled":[307],"Trial":[308],"Number:":[309],"ISRCTN15842444,":[310],"registered":[311],"2":[312],"December":[313],"2022.":[314]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-07-29T00:00:00"}